日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution

AKT 和 EZH2 抑制剂通过劫持退化机制杀死 TNBC

Amy E Schade, Naiara Perurena, Yoona Yang, Carrie L Rodriguez, Anjana Krishnan, Alycia Gardner, Patrick Loi, Yilin Xu, Van T M Nguyen, G M Mastellone, Natalie F Pilla, Marina Watanabe, Keiichi Ota, Rachel A Davis, Kaia Mattioli, Dongxi Xiang, Jason J Zoeller, Jia-Ren Lin, Stefania Morganti, Ana C Ga

Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS-Mutant Colorectal Cancers

表观遗传和致癌抑制剂协同驱动分化并杀死 KRAS 突变型结直肠癌

Patrick Loi #, Amy E Schade #, Carrie L Rodriguez, Anjana Krishnan, Naiara Perurena, Van T M Nguyen, Yilin Xu, Marina Watanabe, Rachel A Davis, Alycia Gardner, Natalie F Pilla, Kaia Mattioli, Olesja Popow, Nuray Gunduz, Tamsin R M Lannagan, Samantha Fitzgerald, Ewa T Sicinska, Jia-Ren Lin, William T

DAB2IP Is a Bifunctional Tumor Suppressor That Regulates Wild-Type RAS and Inflammatory Cascades in KRAS Mutant Colon Cancer

DAB2IP 是一种双功能肿瘤抑制因子,可调节 KRAS 突变结肠癌中的野生型 RAS 和炎症级联

Abigail L Miller, Naiara Perurena, Alycia Gardner, Toshinori Hinoue, Patrick Loi, Peter W Laird, Karen Cichowski

USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable therapeutic vulnerabilities

USP9X 介导胰腺癌对 MAPK 抑制的急性适应性反应,但会产生多个可操作的治疗弱点

Naiara Perurena, Rebecca Lock, Rachel A Davis, Srivatsan Raghavan, Natalie F Pilla, Raymond Ng, Patrick Loi, Caroline J Guild, Abigail L Miller, Ewa Sicinska, James M Cleary, Douglas A Rubinson, Brian M Wolpin, Nathanael S Gray, Sandro Santagata, William C Hahn, Jennifer P Morton, Owen J Sansom, And

Disruption of mitochondrial electron transport chain function potentiates the pro-apoptotic effects of MAPK inhibition

线粒体电子传递链功能破坏增强了 MAPK 抑制的促凋亡作用

Andrew P Trotta, Jesse D Gelles, Madhavika N Serasinghe, Patrick Loi, Jack L Arbiser, Jerry E Chipuk